Living Cell Technologies Ltd. (AU:1AI) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Algorae Pharmaceuticals has expanded its therapeutic pipeline with 24 new AI-generated drug targets for preclinical evaluation, focusing on oncology indications with unmet needs. This development, facilitated by their proprietary AlgoraeOS platform, underscores the company’s competitive edge in AI-driven drug discovery. Successful preclinical outcomes may lead to further development, potentially in collaboration with other pharmaceutical firms.
For further insights into AU:1AI stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue